Antibody Engineering and Therapeutics U.S.

Kevin Heyries, Ph.D. will be presenting “From Patient Sample to Antibody Lead in Three Weeks: A Real-Time Response to COVID-19″ at the virtual Antibody Engineering & Therapeutics U.S.

For more information on AbCellera’s response to COVID-19, click here.